FCRL1 and autoimmune disease: Understanding the complex signaling pathways mediated by FcRL1 and other FcRL family members could provide valuable insights into the formulation of targeted treatments for autoimmune disorders, B-cell malignancies, or other diseases involving aberrant B-cell activation.